210 related articles for article (PubMed ID: 16736417)
21. Exit of catheter lock solutions from double lumen acute haemodialysis catheters--an in vitro study.
Sungur M; Eryuksel E; Yavas S; Bihorac A; Layon AJ; Caruso L
Nephrol Dial Transplant; 2007 Dec; 22(12):3533-7. PubMed ID: 17898024
[TBL] [Abstract][Full Text] [Related]
22. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.
Yevzlin AS; Sanchez RJ; Hiatt JG; Washington MH; Wakeen M; Hofmann RM; Becker YT
Semin Dial; 2007; 20(4):351-4. PubMed ID: 17635828
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of low dose urokinase on dialysis catheter thrombolysis.
Seddon PA; Hrinya MK; Gaynord MA; Lion CM; Mangold BM; Bruns FJ
ASAIO J; 1998; 44(5):M559-61. PubMed ID: 9804494
[TBL] [Abstract][Full Text] [Related]
24. Pharmacomechanical thrombectomy with the Castañeda brush catheter in thrombosed hemodialysis grafts and native fistulas.
Heye S; Van Kerkhove F; Claes K; Maleux G
J Vasc Interv Radiol; 2007 Nov; 18(11):1383-8. PubMed ID: 18003988
[TBL] [Abstract][Full Text] [Related]
25. Recombinant tissue plasminogen activator is a useful alternative to heparin in priming quinton permcath.
Schenk P; Rosenkranz AR; Wölfl G; Hörl WH; Traindl O
Am J Kidney Dis; 2000 Jan; 35(1):130-6. PubMed ID: 10620554
[TBL] [Abstract][Full Text] [Related]
26. Short and long alteplase dwells in dysfunctional hemodialysis catheters.
Macrae JM; Loh G; Djurdjev O; Shalansky S; Werb R; Levin A; Kiaii M
Hemodial Int; 2005 Apr; 9(2):189-95. PubMed ID: 16191068
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters.
Meeus G; Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
Blood Purif; 2005; 23(2):101-5. PubMed ID: 15640601
[TBL] [Abstract][Full Text] [Related]
28. Tissue plasminogen activator (t-PA) efficacy in the restoration of hemodialysis catheter function.
Meers C; Toffelmire EB
CANNT J; 1999; 9(4):25-8. PubMed ID: 15714785
[TBL] [Abstract][Full Text] [Related]
29. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis.
Kaneko Y; Iwano M; Yoshida H; Kosuge M; Ito S; Narita I; Gejyo F; Suzuki M
Blood Purif; 2004; 22(5):473-9. PubMed ID: 15523172
[TBL] [Abstract][Full Text] [Related]
30. Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock.
Agharazii M; Plamondon I; Lebel M; Douville P; Desmeules S
Nephrol Dial Transplant; 2005 Jun; 20(6):1238-40. PubMed ID: 15855206
[TBL] [Abstract][Full Text] [Related]
31. [Permanent catheter as an alternative vascular access for hemodialysis].
Miłkowski A; Kirker A; Smoleński O; Hartwich A; Pietkun Z
Przegl Lek; 1996; 53(11):805-10. PubMed ID: 9173444
[TBL] [Abstract][Full Text] [Related]
32. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
[TBL] [Abstract][Full Text] [Related]
33. High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Shavit L; Lifschitz M; Plaksin J; Grenader T; Slotki I
Clin Nephrol; 2010 Oct; 74(4):297-302. PubMed ID: 20875382
[TBL] [Abstract][Full Text] [Related]
34. Sodium bicarbonate is a potential alternative to classic heparin as a lock solution for non-tunneled dialysis catheters: a result from the prospective randomized BicarbLock trial.
Islam M
Int Urol Nephrol; 2024 Apr; 56(4):1465-1474. PubMed ID: 37823971
[TBL] [Abstract][Full Text] [Related]
35. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
Little MA; Walshe JJ
Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
[TBL] [Abstract][Full Text] [Related]
36. A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters.
Hendrickx L; Kuypers D; Evenepoel P; Maes B; Messiaen T; Vanrenterghem Y
Int J Artif Organs; 2001 Apr; 24(4):208-11. PubMed ID: 11394701
[TBL] [Abstract][Full Text] [Related]
37. Alteplase for blood flow restoration in hemodialysis catheters: a multicenter, randomized, prospective study comparing "dwell" versus "push" administration.
Vercaigne LM; Zacharias J; Bernstein KN
Clin Nephrol; 2012 Oct; 78(4):287-96. PubMed ID: 22541682
[TBL] [Abstract][Full Text] [Related]
38. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
Thomson PC; Morris ST; Mactier RA
Clin Nephrol; 2011 Mar; 75(3):212-7. PubMed ID: 21329631
[TBL] [Abstract][Full Text] [Related]
39. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters (PASSPORT 1).
Kumwenda MJ; Mitra S; Khawaja A; Inston N; Nightingale P
J Vasc Access; 2019 Nov; 20(6):752-759. PubMed ID: 31466489
[TBL] [Abstract][Full Text] [Related]
40. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
